Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 23, 2012

Contest Seeks Innovative Applications for Synthetic Biology

  • More than a million base pairs of custom-designed DNA—valued at over $500,000 based on current average market cost—will be awarded later this year to four winners that demonstrate “creative and innovative” approaches for using synthetic DNA, in the inaugural edition of an annual contest conceived and sponsored by Gen9.

    Gen9’s first-annual G-Prize contest is designed to foster creative and innovative approaches for using synthetic DNA constructs to advance industries including chemical and enzyme production, biofuels, pharmaceuticals, and even data storage. The contest is open only to researchers working at academic or public-benefit organizations, with entries to be judged by a panel of experts selected by Gen9, a developer of next-generation technologies for synthesizing and assembling DNA constructs for use in commercializing DNA synthesis and fabrication platforms.

    The 1st Place winner will receive 500 GeneBits, up to 500kb; while 2nd Place wins 300 GeneBits, up 300kb; and the two 3rd Place winners, 100 GeneBits, up to 100kb to two teams. Any intellectual property rights specific to an entry will remain the sole property of the contestants or their institution, according to Gen9.

    Deadline for entries is Sept. 30. More information is available at www.gen9bio.com/g-prize.

    “We look forward to hearing from the innovative community of researchers who have big ideas for constructively building on the many important industries ripe for modernization via synthetic biology,” Kevin Munnelly, president and CEO of Gen9, said in a statement. “Synthetic biology represents perhaps the greatest opportunity to modernize industry at ‘Moore’s law’ scale since silicon.”

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »